Jocelyne M. Lew

Prince Albert, SK S7N5E3, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial.

Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial.

Journal: Vaccine
Published: July 30, 2025

Recruitment of pulmonary intravascular macrophages in SARS-CoV-2 infected hamsters.

Recruitment of pulmonary intravascular macrophages in SARS-CoV-2 infected hamsters.

Journal: Cell and tissue research
Published: October 07, 2024

Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV.

Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV.

Journal: Virus research
Published: October 04, 2024

Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern.

Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern.

Journal: Vaccine
Published: April 09, 2024

Third COVID-19 vaccine dose boosts antibody function in Rwandans with high HIV viral load.

Third COVID-19 vaccine dose boosts antibody function in Rwandans with high HIV viral load.

Journal: iScience
Published: June 28, 2023

Generation of a SARS-CoV-2 Reverse Genetics System and Novel Human Lung Cell Lines That Exhibit High Virus-Induced Cytopathology.

Generation of a SARS-CoV-2 Reverse Genetics System and Novel Human Lung Cell Lines That Exhibit High Virus-Induced Cytopathology.

Journal: Viruses
Published: April 25, 2023

Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2.

Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2.

Journal: Nature communications
Published: February 22, 2023

Longitudinal analysis of SARS-CoV-2 reinfection reveals distinct kinetics and emergence of cross-neutralizing antibodies to variants of concern.

Longitudinal analysis of SARS-CoV-2 reinfection reveals distinct kinetics and emergence of cross-neutralizing antibodies to variants of concern.

Journal: Frontiers in microbiology
Published: January 19, 2023

SARS-CoV-2 Variant-Specific Infectivity and Immune Profiles Are Detectable in a Humanized Lung Mouse Model.

SARS-CoV-2 Variant-Specific Infectivity and Immune Profiles Are Detectable in a Humanized Lung Mouse Model.

Journal: Viruses
Published: September 01, 2022

Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection.

Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection.

Journal: Scientific reports
Published: February 16, 2022

Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants.

Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants.

Journal: Med (New York, N.Y.)
Published: February 08, 2022

Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.

Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 20, 2021
Showing 1-12 of 22

Last Updated: 09/26/2026